Track LifeMD, Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

LifeMD, Inc. LFMD · Stock Open LifeMD, Inc. in new tab

3.73 USD
EPS
-0.44
P/B
12.18
ROE
-238.45
Beta
1.99
Target Price
9.88 USD
Loading chart...
Key Metrics
Earnings dateAug. 5, 2026
EPS-0.44
Book Value0.32
Price to Book12.18
Debt/Equity41.05
% Insiders13.912%
Growth
Revenue Growth-0.01%
Estimates
Forward P/E7.48
Forward EPS0.52
Target Mean Price9.88

DCF Valuation

Tweak assumptions to recompute fair value for LifeMD, Inc. (LFMD)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

LifeMD, Inc. Logo LifeMD, Inc. Analysis (LFMD)

United States Health Care Official Website Stock

Is LifeMD, Inc. a good investment? LifeMD, Inc. (LFMD) is currently trading at 3.73 USD. Market analysts have a consensus price target of 9.88 USD. This suggests a potential upside from current levels.

Earnings Schedule: LifeMD, Inc. is expected to release its next earnings report on Aug. 5, 2026. The market consensus estimate for Forward EPS is 0.52.

Investor FAQ

Does LifeMD, Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is LifeMD, Inc.?

LifeMD, Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be Aug. 5, 2026. The company currently has a trailing EPS of -0.44.

Company Profile

LifeMD, Inc. operates as a direct-to-patient telehealth company, engages in the provision of patients access to virtual medical care and pharmacy services in the United States. It offers telehealth platform comprising Rex MD, a men's telehealth platform that provides virtual diagnosis, treatment, and prescription medications for men's health conditions, including erectile dysfunction, premature ejaculation, hair loss, insomnia, weight loss, and performance anxiety; and ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss. The company also provides LifeMD PC, a virtual primary care and telehealth service which is a provider for their primary care, urgent care, and chronic care needs; and offers virtual medical care, including on-demand consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, integration with in-home tools, and more. In addition, it offers GLP-1 for weight management and in-home health monitoring devices. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is headquartered in New York, New York.

Exchange Ticker
NMS (United States) LFMD
Trades
Dividend History paid per year (USD)
No dividend history available.
Stock Splits
Split Date Split Ratio to 1
Oct. 14, 2020 0.200000
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion